[go: up one dir, main page]

DE60330764D1 - Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan - Google Patents

Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan

Info

Publication number
DE60330764D1
DE60330764D1 DE60330764T DE60330764T DE60330764D1 DE 60330764 D1 DE60330764 D1 DE 60330764D1 DE 60330764 T DE60330764 T DE 60330764T DE 60330764 T DE60330764 T DE 60330764T DE 60330764 D1 DE60330764 D1 DE 60330764D1
Authority
DE
Germany
Prior art keywords
glucomannan
pharmaceutical composition
composition containing
lipase inhibitor
lipase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60330764T
Other languages
English (en)
Inventor
Jacques Bailly
Rainer Eugen Martin
Susanne Raab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60330764D1 publication Critical patent/DE60330764D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE60330764T 2002-04-26 2003-04-15 Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan Expired - Lifetime DE60330764D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02009254 2002-04-26
PCT/EP2003/003908 WO2003090742A1 (en) 2002-04-26 2003-04-15 Pharmaceutical composition comprising a lipase inhibitor and glucomannan

Publications (1)

Publication Number Publication Date
DE60330764D1 true DE60330764D1 (de) 2010-02-11

Family

ID=29265897

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60330764T Expired - Lifetime DE60330764D1 (de) 2002-04-26 2003-04-15 Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan

Country Status (20)

Country Link
US (2) US20040033983A1 (de)
EP (1) EP1501498B1 (de)
JP (1) JP4234017B2 (de)
KR (1) KR100625399B1 (de)
CN (1) CN1325050C (de)
AR (1) AR039664A1 (de)
AT (1) ATE453390T1 (de)
AU (1) AU2003222814B2 (de)
BR (1) BRPI0309406B1 (de)
CA (1) CA2483002C (de)
DE (1) DE60330764D1 (de)
ES (1) ES2335876T3 (de)
GT (1) GT200300094A (de)
MX (1) MXPA04010371A (de)
PA (1) PA8571901A1 (de)
PE (1) PE20040596A1 (de)
PL (1) PL216022B1 (de)
RU (1) RU2297221C2 (de)
TW (1) TW200404536A (de)
WO (1) WO2003090742A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005280058B2 (en) * 2004-08-25 2010-09-02 Essentialis, Inc. Pharmaceutical formulations of potassium ATP channel openers and uses thereof
ITMI20050010A1 (it) * 2005-01-05 2006-07-06 Aboca S P A Composizioni farmaceutiche nutraceutiche dietetiche nutrizionali a base di fibre vegetali
KR101252635B1 (ko) * 2006-04-20 2013-04-10 (주)아모레퍼시픽 리파아제 저해제 및 친유성 오일흡수제를 포함하는 약학조성물 및 이로부터 제조된 경구 투여용 제제
GB0618725D0 (en) * 2006-09-23 2006-11-01 Jagotec Ag Composition containing inhibitors of gastro-intestinal lipase
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
DE602007008567D1 (de) * 2007-09-12 2010-09-30 Mader S R L Pharmazeutische Zusammensetzungen zur oralen Verabreichung bei der Behandlung von Adipositas-Patienten
US20120053172A1 (en) 2009-02-12 2012-03-01 Cooperatieve Mirzorg U.A. Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
BRPI0901602B8 (pt) * 2009-04-03 2021-05-25 Ems S/A formulação farmacêuticas
US9034342B2 (en) * 2010-03-25 2015-05-19 Gateway Health Alliances, Inc Methods and compositions to reduce fat gain, promote weight loss in animals
WO2012070702A1 (ko) * 2010-11-25 2012-05-31 주식회사 삼양사 올리스태트 및 키토산 함유 조성물 및 그 제조방법
US10507194B2 (en) 2015-08-10 2019-12-17 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for treating obesity
CN108524495B (zh) * 2018-07-10 2019-02-26 中山万汉制药有限公司 奥利司他在制备治疗便秘的药物中的用途
NL2022615B1 (en) 2019-02-21 2020-08-31 Patrick Alexander Unger Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight
CN115671132B (zh) * 2020-06-01 2024-03-15 山东新时代药业有限公司 一种益生菌和益生元的组合物及其应用
WO2023038575A2 (en) * 2021-09-09 2023-03-16 Junion Labs Pte. Ltd. Superabsorbent hydrogels with lipase inhibitor

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582714A (en) * 1982-07-08 1986-04-15 Mars G.B. Limited Air or oil emulsion food product having glucomannas as sole stabilizer-thickener
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
US5477953A (en) * 1992-03-16 1995-12-26 Environmental Products Corporation Filter and filter cleaning system for a reverse vending machine
CA2098167C (en) 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
EP0676967A4 (de) * 1992-12-30 1996-10-02 Fmc Corp Leicht verfügbarer hilfsstoff zur verzögerten freisetzung auf der basis von konjac glukomannan.
WO1998033395A1 (fr) * 1997-02-03 1998-08-06 Takahisa Shiota Aliment prepare a partir d'un sol de farine de konjak
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US5942500A (en) * 1998-04-27 1999-08-24 Perry; Stephen C. Dietary composition to reduce dietary fats
US6093439A (en) * 1998-05-08 2000-07-25 National Starch And Chemical Investment Holding Corporation Hydrocolloid composition for use as a gelling agent viscosifier and stabilizer
KR20010079635A (ko) 1998-08-14 2001-08-22 프리돌린 클라우스너, 롤란드 비. 보레르 리파아제 저해제를 함유하는 약학 조성물
KR20010079636A (ko) * 1998-08-14 2001-08-22 프리돌린 클라우스너, 롤란드 비. 보레르 라이페이즈 저해제 및 키토산을 포함하는 약학 조성물
MXPA02012583A (es) * 2000-06-27 2003-04-10 Hoffmann La Roche Metodo para preparacion de una composicion.
JP4265911B2 (ja) 2000-07-28 2009-05-20 エフ．ホフマン−ラ ロシュ アーゲー 新規医薬組成物
US6558690B2 (en) * 2000-12-15 2003-05-06 Pacific Health Laboratories, Inc. Nutritional composition for improving the efficacy of a lipase inhibitor
JP2004111852A (ja) * 2002-09-20 2004-04-08 Fujitsu Ltd 半導体装置及びその製造方法

Also Published As

Publication number Publication date
AU2003222814A1 (en) 2003-11-10
EP1501498B1 (de) 2009-12-30
RU2297221C2 (ru) 2007-04-20
PL373692A1 (en) 2005-09-05
ATE453390T1 (de) 2010-01-15
US7816342B2 (en) 2010-10-19
JP2005531536A (ja) 2005-10-20
CN1649580A (zh) 2005-08-03
BRPI0309406B1 (pt) 2017-04-11
JP4234017B2 (ja) 2009-03-04
US20040033983A1 (en) 2004-02-19
BR0309406A (pt) 2005-02-01
PA8571901A1 (es) 2004-05-26
TW200404536A (en) 2004-04-01
RU2004134573A (ru) 2005-10-10
AR039664A1 (es) 2005-03-02
KR20040104626A (ko) 2004-12-10
CA2483002A1 (en) 2003-11-06
US20060135471A1 (en) 2006-06-22
WO2003090742A1 (en) 2003-11-06
EP1501498A1 (de) 2005-02-02
AU2003222814B2 (en) 2006-08-24
CN1325050C (zh) 2007-07-11
PE20040596A1 (es) 2004-09-15
KR100625399B1 (ko) 2006-09-20
ES2335876T3 (es) 2010-04-06
GT200300094A (es) 2004-01-15
PL216022B1 (pl) 2014-02-28
MXPA04010371A (es) 2005-02-03
CA2483002C (en) 2011-02-01

Similar Documents

Publication Publication Date Title
KR100984939B9 (ko) 발사르탄 및 ｎｅｐ 저해제를 포함하는 제약학적 조성물
ATE336264T1 (de) Dispergierbare pharmazeutische zusammensetzungen
EP1513825A4 (de) Antituberkulöses arzneimittel: zusammensetzungen und verfahren
ATE263558T1 (de) Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
DE60316902D1 (de) Photopolymerisationsinitiator und photopolymerisierbare Zusammensetzung
IS2504B (is) Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
PT1501534E (pt) Formulacoes farmaceuticas
IL166405A0 (en) 3-z-Ä1-4-(n-((4-methyl-piperazin-1-yl)methylcarbonyl)-n-methyl-aminoanilo)-1-phenyl-methyleneÜ-6-methyxycarbonyl-2-indoline-monoethanesulphonate and the use thereof as a pharmaceutical composition
EP1425019A4 (de) Pharmazeutische zusammensetzung
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
ATE453390T1 (de) Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DE60312049D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
DE60210139D1 (de) Pharmazeutische zusammensetzungen enthaltend tegaserod
EP1496913A4 (de) Neuroprotektive pharmazeutische spirostenol-zusammensetzungen
ATE477814T1 (de) Stabile faktor-viii enthaltende pharmazeutische zusammensetzung
IL165389A0 (en) Piperidine derivatives and pharmaceutical compositions containing the same
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DE60336999D1 (de) Melatonin enthaltende pharmazeutische formulierung
DE60310526D1 (de) Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion
DK1849468T3 (da) Farmaceutisk sammensætning omfattende roflumilast og levocetirizin
NO20033709D0 (no) Medisinske preparater omfattende Diklofenak og Ornoprostil
DE10291905D2 (de) Pharmazeutische Zusammensetzung
IL169163A0 (en) Optically active dihydropyridine derivative and pharmaceutical compositions containing the same
DE60217369D1 (de) Pharmazeutische zusammensetzung enthaltend gamma-butyrobetain

Legal Events

Date Code Title Description
8364 No opposition during term of opposition